product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-PAK2 (Ser20) Antibody
catalog :
2607
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
citations: 2
Published Application/Species/Sample/DilutionReference
  • western blot; human
Kuzelova K, Grebenová D, Holoubek A, Roselova P, Obr A. Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells. PLoS ONE. 2014;9:e92560 pubmed publisher
Elsherif L, Ozler M, Zayed M, Shen J, Chernoff J, Faber J, et al. Potential compensation among group I PAK members in hindlimb ischemia and wound healing. PLoS ONE. 2014;9:e112239 pubmed publisher
product information
SKU :
2607S
Product-Name :
Phospho-PAK2 (Ser20) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, GP, (R)
Applications :
Western blot
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
61 to 67
Host :
Rabbit
Target :
PAK2 (Ser20) phosphate
Primary-Protein :
PAK2
Alt-Names :
C-t-PAK2,Gamma-PAK,PAK-2,PAK-2p27,PAK-2p34,PAK2,PAK65,PAKgamma,S6/H4 kinase,Serine/threonine-protein kinase PAK 2,p21 (CDKN1A)-activated kinase 2,p21 protein (Cdc42/Rac)-activated kinase 2,p21-activated kinase 2,p27,p34,p58
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.